(1)
Alda, J. A.; Soutullo, C.; Ramos-Quiroga, J. A.; Quintero, J.; Hervás, A.; Hernández-Otero, I.; Sans-Fitó, A.; Cardo-Jalón, E.; Fernández-Jaén, A.; Fernández-Pérez, M. Expert Recommendation: Contributions to Clinical Practice of the New Prodrug Lisdexamfetamine Dimesylate (LDX) in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD). Actas Esp Psiquiatr 2014, 42, 1-16.